[1] CUI Z, MENG X, FENG H, et al. Estimation and projection about the standardized prevalence of osteoporosis in (mainland China. Arch Osteoporos. 2019;15(1):2.
[2] 曹志红,丁曼旎,赵彦风.虎产品中医药用史的阶段特征——基于《中华医典》数据库的分析[J]. 自然辩证法通讯,2021,43(7):71-77.
[3] 王鸥,夏维波,成志峰,等.金天格胶囊治疗原发性骨质疏松症的有效性及安全性:随机、双盲双模拟、阳性药平行对照、多中心临床试验[J].中华骨质疏松和骨矿盐疾病杂志,2022,15(2):142-151.
[4] 《中成药治疗优势病种临床应用指南》标准化项目组.中成药治疗骨质疏松症临床应用指南(2021年)[J].中国中西医结合杂志, 2022,42(4):393-404.
[5] YANG Z, YUAN ZZ, MA XL. Network Pharmacology-Based Strategy and Molecular Docking to Explore the (Potential Mechanism of Jintiange Capsule for Treating Osteoporosis. Evid Based Complement Alternat Med. 2021;2021:5338182.
[6] 胡张洁.血清蛋白质组学筛选绝经后骨质疏松生物标志物[D].福州:福建医科大学,2021.
[7] YANG L, HOU A, ZHANG X, et al. TMT-based proteomics analysis to screen potential biomarkers of Achyranthis Bidentatae Radix for osteoporosis in rats. Biomed Chromatogr. 2022;36(4):e5339.
[8] 张建花,沈燚,何玉琼,等.二仙汤抗骨质疏松有效组分对维甲酸致骨丢失大鼠的影响[J].第二军医大学学报,2018,39(2):165-170.
[9] WEN B, ZHOU R, FENG Q, et al. IQuant: an automated pipeline for quantitative proteomics based upon isobaric tags. Proteomics. 2014; 14(20):2280-2285.
[10] SAVITSKI MM, WILHELM M, HAHNE H, et al. A Scalable Approach for Protein False Discovery Rate Estimation in Large Proteomic Data Sets. Mol Cell Proteomics. 2015;14(9):2394-2404.
[11] CHEN C, CHEN H, ZHANG Y, et al. TBtools: An Integrative Toolkit Developed for Interactive Analyses of Big Biological Data. Mol Plant. 2020;13(8):1194-1202.
[12] SHERMAN BT, HAO M, QIU J, et al. DAVID: a web server for functional enrichment analysis and functional annotation (of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216-W221.
[13] KANEHISA M, FURUMICHI M, TANABE M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017; 45(D1):D353-D361.
[14] SZKLARCZYK D, GABLE AL, NASTOU KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605-D612.
[15] TANG Y, LI M, WANG J, et al. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2015;127:67-72.
[16] 高世勇,李婉秋,王帅,等.基于网络药理学的小陷胸汤治疗大肠癌的机制研究[J].中草药,2022,53(3):773-782.
[17] 韩昶晓,田向东,朱光宇,等.金天格胶囊对经皮球囊椎体后凸成形术后患者骨密度、骨代谢及生活质量的影响[J].中国骨质疏松杂志,2021,27(1):110-113.
[18] 林若慧,陈赛楠,叶云金,等.基于TMT蛋白质组学分析骨疏康胶囊治疗骨质疏松模型大鼠的机制[J].中国组织工程研究,2021, 25(32):5141-5147.
[19] GASCHLER MM, STOCKWELL BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482(3):419-425.
[20] KAGAN VE, MAO G, QU F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81-90.
[21] DOLL S, PRONETH B, TYURINA YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017; 13(1):91-98.
[22] CHEN P, SONG M, WANG Y, et al. Identification of key genes of human bone marrow stromal cells adipogenesis at an early stage. PeerJ. 2020; 8:e9484.
[23] KLEIN RF, ALLARD J, AVNUR Z, et al. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science. 2004;303(5655):229-232.
[24] JIANG Z, WANG H, QI G, et al. Iron overload-induced ferroptosis of osteoblasts inhibits osteogenesis and promotes osteoporosis: An in vitro and in vivo study. IUBMB Life. 2022;74(11):1052-1069.
[25] WANG Y, LIU Y, LIU J, et al. NEDD4L-mediated LTF protein degradation limits ferroptosis. Biochem Biophys Res Commun. 2020;531(4):581-587.
[26] SHANG N, WU J. Egg White Ovotransferrin Attenuates RANKL-Induced Osteoclastogenesis and Bone Resorption. Nutrients. 2019;11(9):2254.
[27] CHEN X, KANG R, KROEMER G, et al. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280-296.
[28] 贾鹏,邓廉夫.低氧诱导因子-α信号通路与骨形成[J].中华骨科杂志,2015,35(6):676-680.
[29] NI S, YUAN Y, QIAN Z, et al. Hypoxia inhibits RANKL-induced ferritinophagy and protects osteoclasts from (ferroptosis. Free Radic Biol Med. 2021;169:271-282.
[30] WEI J, YANG Y, LU M, et al. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents. Mini Rev Med Chem. 2018;18(4):296-309.
[31] SEMENZA GL. Pharmacologic Targeting of Hypoxia-Inducible Factors. Annu Rev Pharmacol Toxicol. 2019;59(1):379-403.
[32] BEI J, ZHU S, DU M, et al. Integrative analysis of multiomics data identified acetylation as key variable of (excessive energy metabolism in hyperthyroidism-induced osteoporosis rats. J Proteomics. 2022;252: 104451.
|